Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastrointestinal Tolerability”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01995071
What this trial is testing

Evaluate the Safety and Antiviral Effect of Multiple Doses of ABT-493 and ABT-530 in Adults With Genotype 1 Hepatitis C Virus (HCV)

Who this might be right for
Chronic Hepatitis CHepatitis C VirusCompensated Cirrhosis
AbbVie 89
Testing effectiveness (Phase 2)Study completedNCT01225211
What this trial is testing

Study of VX-809 Alone and in Combination With VX-770 in Cystic Fibrosis (CF) Patients Homozygous or Heterozygous for the F508del-CFTR Mutation

Who this might be right for
Cystic Fibrosis
Vertex Pharmaceuticals Incorporated 312
Testing effectiveness (Phase 2)Study completedNCT00107536
What this trial is testing

Lapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+5 more
National Cancer Institute (NCI) 26
Early research (Phase 1)Looking for participantsNCT07376707
What this trial is testing

TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Metastatic Solid Tumors

Who this might be right for
CRC (Colorectal Cancer)Melanoma (Skin Cancer)HCC - Hepatocellular Carcinoma+1 more
Hefei TG ImmunoPharma Co., Ltd. 194
Testing effectiveness (Phase 2)Ended earlyNCT00962936
What this trial is testing

Safety and Tolerability Study of the Monoclonal Antibody CT-011 in Patients With Chronic Hepatitis C Genotype I Infection

Who this might be right for
Chronic Hepatitis C
CureTech Ltd 13
Early research (Phase 1)Study completedNCT01641536
What this trial is testing

Tolerability, Immunogenicity and Efficacy of HB-110 Administered by Electroporation in Chronic Hepatitis B Patients

Who this might be right for
Hepatitis B, Chronic
Genexine, Inc. 9
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06255912
What this trial is testing

Clinical Trial for Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreas Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 26
Early research (Phase 1)Looking for participantsNCT07275073
What this trial is testing

JMT106 Injection in the Treatment of Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorLung Squamous Cell CarcinomaHepatocellular Carcinoma
Shanghai JMT-Bio Inc. 200
Testing effectiveness (Phase 2)Study completedNCT01054729
What this trial is testing

Dose-Ranging Study of Sofosbuvir in Combination With Pegylated Interferon and Ribavirin in Treatment Naïve GT 1 HCV Patients

Who this might be right for
Hepatitis C
Gilead Sciences 64
Testing effectiveness (Phase 2)Ended earlyNCT03707028
What this trial is testing

Evaluate Safety, Tolerability, and Efficacy Profile of Rivoceranib With Paclitaxel in Advanced Gastric or Gastroesophageal Junction Cancer

Who this might be right for
Gastric CancerGastroesophageal Junction Adenocarcinoma
Elevar Therapeutics 12
Early research (Phase 1)Study completedNCT06128954
What this trial is testing

Study Comparing Once Daily Dose of 900mg of TETA 4HCL Against Cuprior® (450mg Trientine Base, Twice Daily).

Who this might be right for
Wilson's Disease
Orphalan 26
Early research (Phase 1)Study completedNCT06692322
What this trial is testing

Test How Zongertinib is Taken up in the Blood of People With and Without Liver Problems

Who this might be right for
Liver DiseasesHealthy
Boehringer Ingelheim 29
Early research (Phase 1)Active Not RecruitingNCT05984602
What this trial is testing

A Phase IB Study to Determine the Safety and Tolerability of Canakinumab and Tislelizumab in Combination With Nab-Paclitaxel and Gemcitabine in the Neo-adjuvant Treatment of Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
NYU Langone Health 9
Early research (Phase 1)Study completedNCT01099683
What this trial is testing

Safety, Tolerability, Pharmacodynamic and Pharmacokinetics of a Single Rectal Application of 10 mg NRL001 in Elderly Subjects

Who this might be right for
Fecal Incontinence
Norgine 26
Testing effectiveness (Phase 2)Temporarily pausedNCT06039202
What this trial is testing

CA102N Combined With TAS-102 Compared to Bevacizumab Combined With TAS-102 in Subjects With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Holy Stone Healthcare Co., Ltd 100
Testing effectiveness (Phase 2)Study completedNCT02212431
What this trial is testing

First Study of Oral Cysteamine in Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
University of Aberdeen 10
Early research (Phase 1)Looking for participantsNCT05727722
What this trial is testing

Micro-encapsulated Hepatocyte Intraperitoneal Transplantation in Liver Failure Adults

Who this might be right for
Acute-On-Chronic Liver FailureChronic Liver Failure
RenJi Hospital 10
Testing effectiveness (Phase 2)UnknownNCT03485456
What this trial is testing

DPI-Tobra-Kind Cyclops® in Children With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
University Medical Center Groningen 10
Testing effectiveness (Phase 2)Ended earlyNCT01833845
What this trial is testing

Efficacy, Safety and Tolerability of Ribavirin Monotherapy Followed by Combined Treatment With Ribavirin and Hydroxychloroquine in Patients Infected With Hepatitis C

Who this might be right for
Hepatitis C
BioLineRx, Ltd. 4
Testing effectiveness (Phase 2)Ended earlyNCT01440595
What this trial is testing

Grazoprevir (MK-5172) With Peg-Interferon and Ribavirin in Participants With Chronic Genotype 2 or 3 Hepatitis C (MK-5172-012)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 5
Next Page